Immune-related biomarker risk score predicts prognosis in prostate cancer
Figure 5.Construction of the IRG-based prognostic model. (A, B) The number of factors included in the model was determined through LASSO analysis. (C–F) KM curves for PLK1, NLRP14, TNFRSF10D, and FGFR2.